Editing
Testosterone Deficiency (2018)
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==== Administration ==== *'''<span style="color:#ff0000">Available formulations (5):</span>''' *# '''<span style="color:#ff0000">Topical (gel, patch)</span>''' *#* '''Patients should be informed about the risk of transference</span>''' *# '''<span style="color:#ff0000">Buccal patch</span>''' *# '''<span style="color:#ff0000">Nasal gel</span>''' *#'''<span style="color:#ff0000">Subcutaneous pellets</span>''' *#'''<span style="color:#ff0000">Intramuscular injections (3 formulations: 2 short-acting, 1 long-acting)</span>''' *# '''<span style="color:#ff0000">Subcutaneous injections[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293229/ Β§]</span>''' * '''Oral''' ** '''Should not be prescribed''' ** '''Methyltestosterone''' is an oral androgen that is rapidly metabolized in the liver; therefore, achieving consistently therapeutic testosterone levels is a challenge. Its use is also '''associated with liver toxicity''' ** '''Testosterone undecanoate is an oral testosterone''' analogue that is '''absorbed via the intestinal lymphatics allowing it to avoid the first pass liver effect'''. It is approved in some countries for treatment of testosterone deficiency but is not currently approved in the US *'''Native testosterone either orally or parenterally results in absorption by portal circulation and rapid metabolism by the liver, and only a small concentration reaches the systemic circulation.''' Advancement in chemical modification using esterification results in a series of testosterone analogues with improved bioavailability and pharmacokinetics * '''Commercially manufactured testosterone products should be prescribed rather than compounded testosterone, when possible.''' *'''The minimal dose necessary of testosterone therapy should be used to achieve a total testosterone level in the normal physiologic range of 450-600 ng/dL''' (in the middle tertile of the normal reference range) ** Treatments success is defined as achievement of therapeutic testosterone levels to the normal physiologic range of 450 -600 ng/dL accompanied by symptom/sign improvement/resolution.
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information